pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects
Authors
Keywords
Nanomedicine, pH-responsive polymersomes, Doxorubicin, Antitumor activity, Cardiotoxicity
Journal
JOURNAL OF CONTROLLED RELEASE
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-12
DOI
10.1016/j.jconrel.2021.03.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liposomal Drug Delivery Systems and Anticancer Drugs
- (2018) Temidayo Olusanya et al. MOLECULES
- Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
- (2018) Barry Neun et al. MOLECULES
- Drug-Induced Pseudoallergy: A Review of the Causes and Mechanisms
- (2017) Bo Zhang et al. PHARMACOLOGY
- Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies
- (2017) Ana Catarina Alves et al. Scientific Reports
- Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints
- (2017) Tracy Rupp et al. JAMA Internal Medicine
- Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron
- (2016) Iain C. Macdougall et al. AMERICAN JOURNAL OF NEPHROLOGY
- Pharmacokinetics of Polymersomes Composed of Poly(Butadiene-Ethylene Oxide); Healthy versus Tumor-Bearing Mice
- (2016) G. Wang et al. Journal of Biomedical Nanotechnology
- Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
- (2016) Peng Zhang et al. JOURNAL OF CONTROLLED RELEASE
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy
- (2016) L. Simon-Gracia et al. MOLECULAR CANCER THERAPEUTICS
- Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study
- (2015) Miguel J. Gil-Gil et al. BREAST CANCER RESEARCH AND TREATMENT
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
- (2015) Paul H. Kierstead et al. JOURNAL OF CONTROLLED RELEASE
- Polymersomes and their applications in cancer delivery and therapy
- (2015) Lijuan Guan et al. Nanomedicine
- Nanoparticles of the poly([N-(2-hydroxypropyl)]methacrylamide)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymer for pH-triggered release of paclitaxel
- (2015) Alessandro Jäger et al. Polymer Chemistry
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles
- (2013) Can Cui et al. BIOMATERIALS
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Hand-foot syndrome related to chemotherapy
- (2012) J. Qiao et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester
- (2012) Eliézer Jäger et al. JOURNAL OF CONTROLLED RELEASE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- In Vivo Evaluation of Doxorubicin-Loaded (PEG)3-PLA Nanopolymersomes (PolyDoxSome) Using DMBA-Induced Mammary Carcinoma Rat Model and Comparison with Marketed LipoDox™
- (2012) Wubeante Yenet Ayen et al. PHARMACEUTICAL RESEARCH
- Smart polymersomes for therapy and diagnosis: fast progress toward multifunctional biomimetic nanomedicines
- (2012) Hugo De Oliveira et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: Comparison with stealth liposomes
- (2011) Jung Seok Lee et al. JOURNAL OF CONTROLLED RELEASE
- The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice
- (2011) Kamal Kumar Upadhyay et al. Nanomedicine-Nanotechnology Biology and Medicine
- pH-triggered block copolymer micelles based on a pH-responsive PDPA (poly[2-(diisopropylamino)ethyl methacrylate]) inner core and a PEO (poly(ethylene oxide)) outer shell as a potential tool for the cancer therapy
- (2011) Fernando C. Giacomelli et al. Soft Matter
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes
- (2010) Kamal K. Upadhyay et al. BIOMATERIALS
- Polymersomes, smaller than you think: ferrocene as a TEM probe to determine core structure
- (2010) A. H. Johnston et al. JOURNAL OF NANOPARTICLE RESEARCH
- Polymersome production on a microfluidic platform using pH sensitive block copolymers
- (2010) Luke Brown et al. LAB ON A CHIP
- Graphene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy
- (2010) Kai Yang et al. NANO LETTERS
- Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes
- (2010) Yamauchi ONCOLOGY REPORTS
- HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance☆
- (2009) Tamara Minko ADVANCED DRUG DELIVERY REVIEWS
- Phase II Clinical Trial of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having a Therapeutic History of Platinum-based Chemotherapy: A Phase II Study of the Japanese Gynecologic Oncology Group
- (2008) N. Katsumata et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now